Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Little-known facts doctors should be aware of when purchasing the right class of mutual funds

Amarish Dave, DO
Finance
August 16, 2023
Share
Tweet
Share

Investing in mutual funds can be a great investment choice for doctors who often have little time to analyze individual stocks. This is especially true for financial planning for early-career physicians. Mutual funds immediately provide diversification. But have you ever wondered what the letters after the mutual fund mean: A, B, C, or I? Well, picking the right class of a mutual fund can have a big impact on your investment returns.

Class A shares

Cost: Class A shares are known for their upfront sales charges or “loads.” These charges, also referred to as front-end loads, are deducted from the initial investment amount. However, the ongoing annual expenses for Class A shares tend to be lower than other classes. Ask your advisor about breakpoints. This is the amount that if invested can result in a lower charge.

Investment goals: Class A shares are designed for long-term investors who are committed to staying invested for a significant period. They are often associated with actively managed funds, where a professional fund manager makes investment decisions.

Type of investor: Class A shares are suitable for investors who intend to hold onto their investments for several years or more. While the upfront sales charges might appear as a drawback, they can be offset by lower ongoing fees if the investment is held for an extended duration.

Class B shares

Cost: Class B shares are known for their deferred sales charges, also called back-end loads. Instead of upfront charges, investors in Class B shares typically pay a fee when they redeem their shares. The annual expenses for Class B shares can be higher than other classes.

Investment goals: Class B shares often appeal to investors who want to avoid upfront sales charges. However, these shares are designed for intermediate to long-term investors due to the potential redemption fees. They are also associated with active management.

Type of investor: Class B shares might be suitable for investors who plan to hold their investments for a few years and are comfortable with the possibility of deferred charges upon redemption.

Class C shares

Cost: Class C shares are known for their lower upfront sales charges compared to Class A shares. However, they come with higher annual expenses. These shares do not have deferred sales charges, but they might have a “level load,” an ongoing fee that decreases over time.

Investment goals: Class C shares often appeal to investors who want to reduce upfront costs but are comfortable with higher ongoing expenses. Like Class A and B shares, Class C shares are associated with actively managed funds.

Type of investor: Class C shares might be suitable for investors who plan to hold their investments for a relatively short to intermediate period. The declining level load can be advantageous for those who don’t intend to stay invested for the long term.

Class I shares

Cost: Class I shares have no sales loads or transaction fees. They tend to have the lowest annual expenses among mutual fund classes. However, they typically require a higher minimum investment compared to other classes.

Investment goals: Class I shares are aimed at institutional investors, such as pension funds, endowments, and high-net-worth individuals. They are often associated with institutional share classes of funds and are known for their lower costs.

Type of investor: Class I shares are suitable for larger investors who can meet the minimum investment requirements. While they might not be accessible to the average retail investor, they offer a cost-efficient option for institutional clients.

ADVERTISEMENT

Class R shares (retirement shares)

Cost: Class R shares are designed for retirement plans, such as 401(k)s or IRAs. They often have no sales loads and can have varying levels of annual expenses. Class R shares might also have revenue-sharing arrangements, where some of the fund’s expenses are paid by the plan sponsor.

Investment goals: Class R shares are tailored to retirement investors. They can include both actively managed and index funds, offering options for different investment preferences.

Type of investor: Class R shares are suitable for individuals participating in employer-sponsored retirement plans. They provide investment choices specifically curated for retirement goals.

Choosing the right mutual fund class

Selecting the appropriate mutual fund class depends on your investment goals, time horizon, risk tolerance, and preferences. Consider these factors alongside the costs associated with each class. It’s also essential to evaluate the specific mutual fund’s performance history, investment strategy, and the expertise of the fund manager.

Remember that while mutual fund classes offer choices, the underlying goal remains consistent: to help investors achieve their financial objectives. By understanding the nuances of each mutual fund class, you can make informed decisions that align with your unique investment journey. Consulting with a financial advisor can provide valuable insights tailored to your individual circumstances and goals.

Amarish Dave is a board-certified neurologist with over 20 years of experience in both neurology and active stock investing. In addition to his medical career, he holds a background in business from the University of Michigan and has successfully passed the SIE exam administered by FINRA. Dr. Dave is founder, FiscalhealthMD.com, a website dedicated to educating doctors at all stages of their careers, ranging from residents to retirement, about financial planning.

Prev

The struggle of a computer-based doctor

August 16, 2023 Kevin 2
…
Next

Removing workflow burdens and improving access for colorectal cancer screenings

August 16, 2023 Kevin 0
…

Tagged as: Practice Management

Post navigation

< Previous Post
The struggle of a computer-based doctor
Next Post >
Removing workflow burdens and improving access for colorectal cancer screenings

ADVERTISEMENT

More by Amarish Dave, DO

  • The doctor’s guide to dividend wealth: Building a resilient portfolio with smart investments

    Amarish Dave, DO
  • What to put in Roth vs. traditional IRAs: It can make big differences

    Amarish Dave, DO
  • How to select the right mutual funds for your goals

    Amarish Dave, DO

Related Posts

  • When doctors are right

    Sophia Zilber
  • We’re doctors. We signed the book.

    Jonathan Peters, MD
  • Why doctors-in-training need better nutritional education

    Abeer Arain, MD, MPH
  • Who says doctors don’t care?

    Cindy Thompson
  • Should doctors take more responsibility for quality metrics?

    Sarah Gebauer, MD
  • Doctors, do you really understand?

    Michele Luckenbaugh

More in Finance

  • How new physicians can build their career

    David B. Mandell, JD, MBA
  • Why doctors make bad financial decisions

    Wesley J. McBride, MD, CFP
  • First physician employment agreement mistakes

    Dennis Hursh, Esq
  • Why physicians need a personal CFO and how tax mitigation fits in

    Erik Brenner, CFP
  • The link between financial literacy and physician burnout

    Hayley Gates & Ketan Kulkarni, MD
  • Building a practice and avoiding business pitfalls

    David B. Mandell, JD, MBA
  • Most Popular

  • Past Week

    • The high cost of PCSK9 inhibitors like Repatha

      Larry Kaskel, MD | Conditions
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Rethinking cholesterol and atherosclerosis

      Larry Kaskel, MD | Conditions
    • Diagnosing the epidemic of U.S. violence

      Brian Lynch, MD | Physician
    • A neurosurgeon’s fight with the state medical board [PODCAST]

      The Podcast by KevinMD | Podcast
    • Telehealth licensing barriers hurt patients

      Ryan Nadelson, MD | Physician
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The mental health workforce is collapsing

      Ronke Lawal | Conditions
    • A doctor’s struggle with burnout and boundaries

      Humeira Badsha, MD | Physician
    • The stoic cure for modern anxiety

      Osmund Agbo, MD | Physician
  • Recent Posts

    • Telehealth licensing barriers hurt patients

      Ryan Nadelson, MD | Physician
    • Physician suicide prevention: a call to action

      Muhamad Aly Rifai, MD | Conditions
    • When a rural hospital dies

      Dalia Saha, MD | Physician
    • When a good radiologist is accused of fraud

      Daniel Cousin, MD | Physician
    • Who wants to live to be a hundred?

      Althea Halchuck, EJD | Conditions
    • Passing the medical boards at age 63 [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The high cost of PCSK9 inhibitors like Repatha

      Larry Kaskel, MD | Conditions
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Rethinking cholesterol and atherosclerosis

      Larry Kaskel, MD | Conditions
    • Diagnosing the epidemic of U.S. violence

      Brian Lynch, MD | Physician
    • A neurosurgeon’s fight with the state medical board [PODCAST]

      The Podcast by KevinMD | Podcast
    • Telehealth licensing barriers hurt patients

      Ryan Nadelson, MD | Physician
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The mental health workforce is collapsing

      Ronke Lawal | Conditions
    • A doctor’s struggle with burnout and boundaries

      Humeira Badsha, MD | Physician
    • The stoic cure for modern anxiety

      Osmund Agbo, MD | Physician
  • Recent Posts

    • Telehealth licensing barriers hurt patients

      Ryan Nadelson, MD | Physician
    • Physician suicide prevention: a call to action

      Muhamad Aly Rifai, MD | Conditions
    • When a rural hospital dies

      Dalia Saha, MD | Physician
    • When a good radiologist is accused of fraud

      Daniel Cousin, MD | Physician
    • Who wants to live to be a hundred?

      Althea Halchuck, EJD | Conditions
    • Passing the medical boards at age 63 [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...